High-Protein Intake during Weight Loss Therapy Eliminates the Weight-Loss-Induced Improvement in Insulin Action in Obese Postmenopausal Women

Cell Reports

Volumn 17, Issue 3, 2016, Pages 849-861

  Smith, Gordon I ^a   Yoshino, Jun ^a   Kelly, Shannon C ^a   Reeds, Dominic N ^a   Okunade, Adewole ^a   Patterson, Bruce W ^a   Klein, Samuel ^a   Mittendorfer, Bettina ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

amino acids; calorie restriction; high protein diet; insulin resistance; insulin sensitivity; protein; skeletal muscle; weight loss

Indexed keywords

INSULIN; BIOLOGICAL MARKER; FATTY ACID; HORMONE; PALMITIC ACID;

ADULT; ARTICLE; CELL STRUCTURE; CLINICAL ARTICLE; FEMALE; GENETIC TRANSCRIPTION; GLUCOSE TRANSPORT; HUMAN; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LOW CALORY DIET; OBESITY; OXIDATIVE STRESS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN DIET; WEIGHT REDUCTION; BLOOD; CLINICAL TRIAL; DIET THERAPY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; INFLAMMATION; KINETICS; LIPOGENESIS; METABOLISM; METABOLOME; MIDDLE AGED; MITOCHONDRION; MUSCLE; OXIDATION REDUCTION REACTION; PATHOLOGY; PROTEIN INTAKE; THERAPEUTIC USE;

BIOMARKERS; BLOOD GLUCOSE; DIET, REDUCING; DIETARY PROTEINS; FATTY ACIDS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HORMONES; HUMANS; INFLAMMATION; INSULIN; KINETICS; LIPOGENESIS; METABOLOME; MIDDLE AGED; MITOCHONDRIA; MUSCLES; OBESITY; OXIDATION-REDUCTION; OXIDATIVE STRESS; PALMITIC ACID; POSTMENOPAUSE; WEIGHT LOSS;

EID: 84992170253     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.09.047     Document Type: Article

References (67)

1. Anderson, E.J., Lustig, M.E., Boyle, K.E., Woodlief, T.L., Kane, D.A., Lin, C.T., Price, J.W. 3rd, Kang, L., Rabinovitch, P.S., Szeto, H.H., et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J. Clin. Invest. 119 (2009), 573–581.
2. Ang, M., Müller, A.S., Wagenlehner, F., Pilatz, A., Linn, T., Combining protein and carbohydrate increases postprandial insulin levels but does not improve glucose response in patients with type 2 diabetes. Metabolism 61 (2012), 1696–1702.
3. Asrih, M., Pellieux, C., Papageorgiou, I., Lerch, R., Montessuit, C., Role of ERK1/2 activation in microtubule stabilization and glucose transport in cardiomyocytes. Am. J. Physiol. Endocrinol. Metab. 301 (2011), E836–E843.
4. Black, A.E., Coward, W.A., Cole, T.J., Prentice, A.M., Human energy expenditure in affluent societies: an analysis of 574 doubly-labelled water measurements. Eur. J. Clin. Nutr. 50 (1996), 72–92.
5. Boden, G., Chen, X., Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J. Clin. Invest. 96 (1995), 1261–1268.
6. Bose, A., Guilherme, A., Robida, S.I., Nicoloro, S.M., Zhou, Q.L., Jiang, Z.Y., Pomerleau, D.P., Czech, M.P., Glucose transporter recycling in response to insulin is facilitated by myosin Myo1c. Nature 420 (2002), 821–824.
7. Brozinick, J.T. Jr., Berkemeier, B.A., Elmendorf, J.S., “Actin”g on GLUT4: membrane & cytoskeletal components of insulin action. Curr. Diabetes Rev. 3 (2007), 111–122.
8. Camporez, J.P., Jornayvaz, F.R., Petersen, M.C., Pesta, D., Guigni, B.A., Serr, J., Zhang, D., Kahn, M., Samuel, V.T., Jurczak, M.J., Shulman, G.I., Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice. Endocrinology 154 (2013), 3099–3109.
9. Chen, X.W., Leto, D., Chiang, S.H., Wang, Q., Saltiel, A.R., Activation of RalA is required for insulin-stimulated Glut4 trafficking to the plasma membrane via the exocyst and the motor protein Myo1c. Dev. Cell 13 (2007), 391–404.
10. Conte, C., Fabbrini, E., Kars, M., Mittendorfer, B., Patterson, B.W., Klein, S., Multiorgan insulin sensitivity in lean and obese subjects. Diabetes Care 35 (2012), 1316–1321.
11. Fabbrini, E., Yoshino, J., Yoshino, M., Magkos, F., Tiemann Luecking, C., Samovski, D., Fraterrigo, G., Okunade, A.L., Patterson, B.W., Klein, S., Metabolically normal obese people are protected from adverse effects following weight gain. J. Clin. Invest. 125 (2015), 787–795.
12. Fazeli, P.K., Lun, M., Kim, S.M., Bredella, M.A., Wright, S., Zhang, Y., Lee, H., Catana, C., Klibanski, A., Patwari, P., Steinhauser, M.L., FGF21 and the late adaptive response to starvation in humans. J. Clin. Invest. 125 (2015), 4601–4611.
13. Floyd, J.C. Jr., Fajans, S.S., Conn, J.W., Knopf, R.F., Rull, J., Insulin secretion in response to protein ingestion. J. Clin. Invest. 45 (1966), 1479–1486.
14. Forni, S., Fu, X., Palmer, S.E., Sweetman, L., Rapid determination of C4-acylcarnitine and C5-acylcarnitine isomers in plasma and dried blood spots by UPLC-MS/MS as a second tier test following flow-injection MS/MS acylcarnitine profile analysis. Mol. Genet. Metab. 101 (2010), 25–32.
15. Frimel, T.N., Deivanayagam, S., Bashir, A., O'Connor, R., Klein, S., Assessment of intrahepatic triglyceride content using magnetic resonance spectroscopy. J. Cardiometab. Syndr. 2 (2007), 136–138.
16. Frohnert, B.I., Long, E.K., Hahn, W.S., Bernlohr, D.A., Glutathionylated lipid aldehydes are products of adipocyte oxidative stress and activators of macrophage inflammation. Diabetes 63 (2014), 89–100.
17. Gälman, C., Lundåsen, T., Kharitonenkov, A., Bina, H.A., Eriksson, M., Hafström, I., Dahlin, M., Amark, P., Angelin, B., Rudling, M., The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. Cell Metab. 8 (2008), 169–174.
18. Groop, L.C., Insulin resistance: the fundamental trigger of type 2 diabetes. Diabetes Obes. Metab. 1:Suppl 1 (1999), S1–S7.
19. Hattersley, J.G., Pfeiffer, A.F., Roden, M., Petzke, K.J., Hoffmann, D., Rudovich, N.N., Randeva, H.S., Vatish, M., Osterhoff, M., Goegebakan, Ö., et al. Modulation of amino acid metabolic signatures by supplemented isoenergetic diets differing in protein and cereal fiber content. J. Clin. Endocrinol. Metab. 99 (2014), E2599–E2609.
20. Houston, D.K., Nicklas, B.J., Zizza, C.A., Weighty concerns: the growing prevalence of obesity among older adults. J. Am. Diet. Assoc. 109 (2009), 1886–1895.
21. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. 2005, The National Academies Press, Washington, DC.
22. Iwanaka, N., Egawa, T., Satoubu, N., Karaike, K., Ma, X., Masuda, S., Hayashi, T., Leucine modulates contraction- and insulin-stimulated glucose transport and upstream signaling events in rat skeletal muscle. J. Appl. Physiol. 108 (2010), 274–282.
23. Kim, S.Y., Volsky, D.J., PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics, 6, 2005, 144.
24. Kim, K., Yu, M., Han, S., Oh, I., Choi, Y.J., Kim, S., Yoon, K., Jung, M., Choe, W., Expression of human peroxiredoxin isoforms in response to cervical carcinogenesis. Oncol. Rep. 21 (2009), 1391–1396.
25. Kirk, E.P., Klein, S., Pathogenesis and pathophysiology of the cardiometabolic syndrome. J. Clin. Hypertens. (Greenwich) 11 (2009), 761–765.
26. Klein, S., Outcome success in obesity. Obes. Res. 9:Suppl 4 (2001), 354S–358S.
27. Klip, A., Sun, Y., Chiu, T.T., Foley, K.P., Signal transduction meets vesicle traffic: the software and hardware of GLUT4 translocation. Am. J. Physiol. Cell Physiol. 306 (2014), C879–C886.
28. Krebs, M., Krssak, M., Bernroider, E., Anderwald, C., Brehm, A., Meyerspeer, M., Nowotny, P., Roth, E., Waldhäusl, W., Roden, M., Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. Diabetes 51 (2002), 599–605.
29. Krebs, M., Brunmair, B., Brehm, A., Artwohl, M., Szendroedi, J., Nowotny, P., Roth, E., Fürnsinn, C., Promintzer, M., Anderwald, C., et al. The mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man. Diabetes 56 (2007), 1600–1607.
30. Laeger, T., Henagan, T.M., Albarado, D.C., Redman, L.M., Bray, G.A., Noland, R.C., Münzberg, H., Hutson, S.M., Gettys, T.W., Schwartz, M.W., Morrison, C.D., FGF21 is an endocrine signal of protein restriction. J. Clin. Invest. 124 (2014), 3913–3922.
31. Leidy, H.J., Clifton, P.M., Astrup, A., Wycherley, T.P., Westerterp-Plantenga, M.S., Luscombe-Marsh, N.D., Woods, S.C., Mattes, R.D., The role of protein in weight loss and maintenance. Am. J. Clin. Nutr. 101 (2015), 1320S–1329S.
32. Linn, T., Geyer, R., Prassek, S., Laube, H., Effect of dietary protein intake on insulin secretion and glucose metabolism in insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 81 (1996), 3938–3943.
33. Liu, L.Z., Cheung, S.C., Lan, L.L., Ho, S.K., Chan, J.C., Tong, P.C., Microtubule network is required for insulin-induced signal transduction and actin remodeling. Mol. Cell. Endocrinol. 365 (2013), 64–74.
34. Magkos, F., Patterson, B.W., Mohammed, B.S., Klein, S., Mittendorfer, B., Women produce fewer but triglyceride-richer very low-density lipoproteins than men. J. Clin. Endocrinol. Metab. 92 (2007), 1311–1318.
35. Manders, R.J., Hansen, D., Zorenc, A.H., Dendale, P., Kloek, J., Saris, W.H., van Loon, L.J., Protein co-ingestion strongly increases postprandial insulin secretion in type 2 diabetes patients. J. Med. Food 17 (2014), 758–763.
36. Markan, K.R., Naber, M.C., Ameka, M.K., Anderegg, M.D., Mangelsdorf, D.J., Kliewer, S.A., Mohammadi, M., Potthoff, M.J., Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. Diabetes 63 (2014), 4057–4063.
37. Mashili, F.L., Austin, R.L., Deshmukh, A.S., Fritz, T., Caidahl, K., Bergdahl, K., Zierath, J.R., Chibalin, A.V., Moller, D.E., Kharitonenkov, A., Krook, A., Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Diabetes Metab. Res. Rev. 27 (2011), 286–297.
38. Mittendorfer, B., Liem, O., Patterson, B.W., Miles, J.M., Klein, S., What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean?. Diabetes 52 (2003), 1641–1648.
39. Mittendorfer, B., Patterson, B.W., Klein, S., Effect of sex and obesity on basal VLDL-triacylglycerol kinetics. Am. J. Clin. Nutr. 77 (2003), 573–579.
40. Muoio, D.M., Neufer, P.D., Lipid-induced mitochondrial stress and insulin action in muscle. Cell Metab. 15 (2012), 595–605.
41. Newgard, C.B., An, J., Bain, J.R., Muehlbauer, M.J., Stevens, R.D., Lien, L.F., Haqq, A.M., Shah, S.H., Arlotto, M., Slentz, C.A., et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9 (2009), 311–326.
42. Pedersen, B.K., IL-6 signalling in exercise and disease. Biochem. Soc. Trans. 35 (2007), 1295–1297.
43. Petersen, K.F., Shulman, G.I., Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am. J. Cardiol. 90:5A (2002), 11G–18G.
44. Phillips, S.K., Rook, K.M., Siddle, N.C., Bruce, S.A., Woledge, R.C., Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin. Sci. 84 (1993), 95–98.
45. Raza, H., Robin, M.A., Fang, J.K., Avadhani, N.G., Multiple isoforms of mitochondrial glutathione S-transferases and their differential induction under oxidative stress. Biochem. J. 366 (2002), 45–55.
46. Rietman, A., Schwarz, J., Tomé, D., Kok, F.J., Mensink, M., High dietary protein intake, reducing or eliciting insulin resistance?. Eur. J. Clin. Nutr. 68 (2014), 973–979.
47. Robinson, M.M., Soop, M., Sohn, T.S., Morse, D.M., Schimke, J.M., Klaus, K.A., Nair, K.S., High insulin combined with essential amino acids stimulates skeletal muscle mitochondrial protein synthesis while decreasing insulin sensitivity in healthy humans. J. Clin. Endocrinol. Metab. 99 (2014), E2574–E2583.
48. Roden, M., Price, T.B., Perseghin, G., Petersen, K.F., Rothman, D.L., Cline, G.W., Shulman, G.I., Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest. 97 (1996), 2859–2865.
49. Saha, A.K., Xu, X.J., Balon, T.W., Brandon, A., Kraegen, E.W., Ruderman, N.B., Insulin resistance due to nutrient excess: is it a consequence of AMPK downregulation?. Cell Cycle 10 (2011), 3447–3451.
50. Samson, M.M., Meeuwsen, I.B., Crowe, A., Dessens, J.A., Duursma, S.A., Verhaar, H.J., Relationships between physical performance measures, age, height and body weight in healthy adults. Age Ageing 29 (2000), 235–242.
51. Schooneman, M.G., Vaz, F.M., Houten, S.M., Soeters, M.R., Acylcarnitines: reflecting or inflicting insulin resistance?. Diabetes 62 (2013), 1–8.
52. Schröder, E., Brennan, J.P., Eaton, P., Cardiac peroxiredoxins undergo complex modifications during cardiac oxidant stress. Am. J. Physiol. Heart Circ. Physiol. 295 (2008), H425–H433.
53. Schwingshackl, L., Hoffmann, G., Long-term effects of low-fat diets either low or high in protein on cardiovascular and metabolic risk factors: a systematic review and meta-analysis. Nutr. J., 12, 2013, 48.
54. Sluijs, I., Beulens, J.W., van der A, D.L., Spijkerman, A.M., Grobbee, D.E., van der Schouw, Y.T., Dietary intake of total, animal, and vegetable protein and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-NL Study. Diabetes Care 33 (2010), 43–48.
55. Smith, G.I., Yoshino, J., Reeds, D.N., Bradley, D., Burrows, R.E., Heisey, H.D., Moseley, A.C., Mittendorfer, B., Testosterone and progesterone, but not estradiol, stimulate muscle protein synthesis in postmenopausal women. J. Clin. Endocrinol. Metab. 99 (2014), 256–265.
56. Smith, G.I., Yoshino, J., Stromsdorfer, K.L., Klein, S.J., Magkos, F., Reeds, D.N., Klein, S., Mittendorfer, B., Protein ingestion induces muscle insulin resistance independent of leucine-mediated mTOR activation. Diabetes 64 (2015), 1555–1563.
57. Tinker, L.F., Sarto, G.E., Howard, B.V., Huang, Y., Neuhouser, M.L., Mossavar-Rahmani, Y., Beasley, J.M., Margolis, K.L., Eaton, C.B., Phillips, L.S., Prentice, R.L., Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative. Am. J. Clin. Nutr. 94 (2011), 1600–1606.
58. Tremblay, F., Jacques, H., Marette, A., Modulation of insulin action by dietary proteins and amino acids: role of the mammalian target of rapamycin nutrient sensing pathway. Curr. Opin. Clin. Nutr. Metab. Care 8 (2005), 457–462.
59. Tsai, S., Sitzmann, J.M., Dastidar, S.G., Rodriguez, A.A., Vu, S.L., McDonald, C.E., Academia, E.C., O'Leary, M.N., Ashe, T.D., La Spada, A.R., Kennedy, B.K., Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity. J. Clin. Invest. 125 (2015), 2952–2964.
60. Whitaker, H.C., Patel, D., Howat, W.J., Warren, A.Y., Kay, J.D., Sangan, T., Marioni, J.C., Mitchell, J., Aldridge, S., Luxton, H.J., et al. Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress. Br. J. Cancer 109 (2013), 983–993.
61. Wolfe, R.R., Miller, S.L., Miller, K.B., Optimal protein intake in the elderly. Clin. Nutr. 27 (2008), 675–684.
62. Wycherley, T.P., Moran, L.J., Clifton, P.M., Noakes, M., Brinkworth, G.D., Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 96 (2012), 1281–1298.
63. Xu, J., Lloyd, D.J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.S., Lindberg, R.A., et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58 (2009), 250–259.
64. Yoshino, J., Mills, K.F., Yoon, M.J., Imai, S., Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 14 (2011), 528–536.
65. Yoshino, J., Conte, C., Fontana, L., Mittendorfer, B., Imai, S., Schechtman, K.B., Gu, C., Kunz, I., Rossi Fanelli, F., Patterson, B.W., Klein, S., Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab. 16 (2012), 658–664.
66. Yoshino, J., Almeda-Valdes, P., Patterson, B.W., Okunade, A.L., Imai, S., Mittendorfer, B., Klein, S., Diurnal variation in insulin sensitivity of glucose metabolism is associated with diurnal variations in whole-body and cellular fatty acid metabolism in metabolically normal women. J. Clin. Endocrinol. Metab. 99 (2014), E1666–E1670.
67. Zaid, H., Antonescu, C.N., Randhawa, V.K., Klip, A., Insulin action on glucose transporters through molecular switches, tracks and tethers. Biochem. J. 413 (2008), 201–215.